Here are five things to know about Dr. Hurlbert.
1. He succeeds Margaret “Peg” Mastrianni, who will retire in January 2016 after serving as BCRF’s deputy director and chief program officer for more than 14 years.
2. In his new role, Dr. Hurlbert will oversee the foundation’s global research grants program and a nearly $50 million annual research-granting budget, officials said. He will also continue to lead the Metastatic Breast Cancer Alliance, which comprises nearly 40 breast cancer and cancer nonprofits, private funders, industry partners and individuals.
3. Previously, he was executive director of the Avon Breast Cancer Crusade, which works to help prevent, treat, and ultimately eradicate breast cancer.
4. Dr. Hurlbert was also chairman of the board of the International Cancer Research Partnership, the Health Research Alliance and is also the former chairman of the Cancer Committee Advisory Board for the NewYork-Presbyterian Hospital in New York City.
5. He has a Doctor of Philosophy in pharmacology and prior experience as a pharmacologist.
More articles on healthcare executive moves:
Saint Joseph Hospital gets new president: 6 things to know
Erlanger picks Floyd Chasse as HR head: 3 things to know
Center for Health Affairs names chief of staff: 5 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
